Intravenous ascorbic acid infusion improves myocardial perfusion grade during elective percutaneous coronary intervention: relationship with oxidative stress markers
- PMID: 20170881
- DOI: 10.1016/j.jcin.2009.10.025
Intravenous ascorbic acid infusion improves myocardial perfusion grade during elective percutaneous coronary intervention: relationship with oxidative stress markers
Abstract
Objectives: Our goal was to explore whether antioxidant vitamin C infusion is able to affect the microcirculation perfusion in patients undergoing elective percutaneous coronary intervention for stable angina.
Background: Periprocedural myocardial injury in the setting of elective percutaneous coronary intervention is associated with increased risk of death, recurrent infarction, and revascularization at follow-up. Despite excellent epicardial blood flow, impaired microcirculatory reperfusion may persist and increases the risk of vascular recurrences. Post-percutaneous coronary intervention induced-oxidative stress is one of the potential mechanisms accounting for impaired perfusion.
Methods: Fifty-six patients were enrolled in a prospective, single-center, randomized study comparing 1 g vitamin C infusion (16.6 mg/min, over 1 h before percutaneous coronary intervention) versus placebo.
Results: At the baseline, Thrombolysis In Myocardial Infarction (TIMI) myocardial perfusion grade <2 was observed in 89% and in 86% of patients randomized to the placebo or vitamin C infusion group, respectively (p > 0.05). After percutaneous coronary intervention, these percentages decreased in the placebo group (32%) and in greater measure in the vitamin C group (4%, p < 0.01). Complete microcirculatory reperfusion (TIMI myocardial perfusion grade = 3) was achieved in 79% of the vitamin C-treated group compared with 39% of the placebo group (p < 0.01); 8-hydroxy-2-deoxyguanosine (p < 0.002) and 8-iso-prostaglandin F(2alpha) (p < 0.02) plasma levels significantly increased in the placebo group while they were significantly reduced in the vitamin C-treated group (p < 0.0001). TIMI myocardial perfusion grade changes from the baseline showed significant correlation with 8-hydroxy-2-deoxyguanosine (p < 0.006) or 8-iso-prostaglandin F(2alpha) (p < 0.01) plasma levels changes.
Conclusions: In patients undergoing elective percutaneous coronary intervention, impaired microcirculatory reperfusion is improved by vitamin C infusion suggesting that oxidative stress is implicated in such a phenomenon.
Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Vitamin C and percutaneous coronary intervention.JACC Cardiovasc Interv. 2010 Feb;3(2):230-2. doi: 10.1016/j.jcin.2009.12.003. JACC Cardiovasc Interv. 2010. PMID: 20170882 Free PMC article.
Similar articles
-
Ascorbic acid infusion blunts CD40L upregulation in patients undergoing coronary stent.Cardiovasc Ther. 2011 Dec;29(6):385-94. doi: 10.1111/j.1755-5922.2010.00168.x. Epub 2010 Jul 12. Cardiovasc Ther. 2011. PMID: 20629665 Clinical Trial.
-
The effect of intravenous vitamin C infusion on periprocedural myocardial injury for patients undergoing elective percutaneous coronary intervention.Can J Cardiol. 2014 Jan;30(1):96-101. doi: 10.1016/j.cjca.2013.08.018. Can J Cardiol. 2014. PMID: 24365194 Clinical Trial.
-
The impact of pravastatin pre-treatment on periprocedural microcirculatory damage in patients undergoing percutaneous coronary intervention.JACC Cardiovasc Interv. 2011 May;4(5):513-20. doi: 10.1016/j.jcin.2011.02.005. JACC Cardiovasc Interv. 2011. PMID: 21596324 Clinical Trial.
-
Joint Cardioprotective Effect of Vitamin C and Other Antioxidants against Reperfusion Injury in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.Molecules. 2021 Sep 21;26(18):5702. doi: 10.3390/molecules26185702. Molecules. 2021. PMID: 34577176 Free PMC article. Review.
-
Vitamin C for Cardiac Protection during Percutaneous Coronary Intervention: A Systematic Review of Randomized Controlled Trials.Nutrients. 2020 Jul 23;12(8):2199. doi: 10.3390/nu12082199. Nutrients. 2020. PMID: 32718091 Free PMC article.
Cited by
-
Glutathione infusion before primary percutaneous coronary intervention: a randomised controlled pilot study.BMJ Open. 2019 Aug 8;9(8):e025884. doi: 10.1136/bmjopen-2018-025884. BMJ Open. 2019. PMID: 31399448 Free PMC article. Clinical Trial.
-
Vitamin C Can Shorten the Length of Stay in the ICU: A Meta-Analysis.Nutrients. 2019 Mar 27;11(4):708. doi: 10.3390/nu11040708. Nutrients. 2019. PMID: 30934660 Free PMC article.
-
Association of Smoking and Other Factors With the Outcome of Mohs Reconstruction Using Flaps or Grafts.JAMA Facial Plast Surg. 2019 Sep 1;21(5):407-413. doi: 10.1001/jamafacial.2019.0243. JAMA Facial Plast Surg. 2019. PMID: 31194217 Free PMC article.
-
The Combined Treatment of Glutathione Sodium Salt and Ascorbic Acid for Preventing Contrast-Associated Acute Kidney Injury in ST-Elevation Myocardial Infarction Patients Undergoing Primary PCI: A Hypothesis to Be Validated.Antioxidants (Basel). 2023 Mar 22;12(3):773. doi: 10.3390/antiox12030773. Antioxidants (Basel). 2023. PMID: 36979021 Free PMC article.
-
Making sense of early high-dose intravenous vitamin C in ischemia/reperfusion injury.Crit Care. 2018 Mar 20;22(1):70. doi: 10.1186/s13054-018-1996-y. Crit Care. 2018. PMID: 29558975 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical